5:22 PM
 | 
Oct 29, 2012
 |  BC Extra  |  Company News

Chugai to co-develop diabetes candidate in Japan with Kowa, Sanofi

Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) granted Kowa Co. Ltd. (Nagoya, Japan) and Sanofi (Euronext:SAN; NYSE:SNY) rights to co-develop Chugai's diabetes compound CSG452 in...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >